JP2024540198A5 - - Google Patents
Info
- Publication number
- JP2024540198A5 JP2024540198A5 JP2024525777A JP2024525777A JP2024540198A5 JP 2024540198 A5 JP2024540198 A5 JP 2024540198A5 JP 2024525777 A JP2024525777 A JP 2024525777A JP 2024525777 A JP2024525777 A JP 2024525777A JP 2024540198 A5 JP2024540198 A5 JP 2024540198A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- pharmaceutical composition
- composition according
- bond
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163274722P | 2021-11-02 | 2021-11-02 | |
| US63/274,722 | 2021-11-02 | ||
| PCT/US2022/048669 WO2023081185A1 (en) | 2021-11-02 | 2022-11-02 | Methods of treating respiratory depression modulated by a non-opioid agent |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024540198A JP2024540198A (ja) | 2024-10-31 |
| JP2024540198A5 true JP2024540198A5 (https=) | 2025-11-11 |
Family
ID=86147248
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024525777A Pending JP2024540198A (ja) | 2021-11-02 | 2022-11-02 | 非オピオイド剤によって調節される呼吸抑制を治療する方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US12138267B2 (https=) |
| EP (1) | EP4426308A4 (https=) |
| JP (1) | JP2024540198A (https=) |
| KR (1) | KR20240101622A (https=) |
| CN (1) | CN118488840A (https=) |
| AU (1) | AU2022380482A1 (https=) |
| CA (1) | CA3236586A1 (https=) |
| MX (1) | MX2024005389A (https=) |
| TW (1) | TW202333730A (https=) |
| WO (1) | WO2023081185A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2025511227A (ja) * | 2022-04-01 | 2025-04-15 | エナラーレ セラピューティクス インコーポレイテッド | 呼吸器刺激性経鼻製剤 |
| US20230414624A1 (en) * | 2022-06-24 | 2023-12-28 | Enalare Therapeutics Inc. | Methods of treating neurological ventilatory insufficiency |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4508715A (en) | 1981-07-01 | 1985-04-02 | University Of Georgia Research Foundation, Inc. | Antagonism of central nervous system drugs by the administration of 4-aminopyridine alone or in combination with other drugs |
| AU2011322147A1 (en) * | 2010-10-26 | 2013-04-18 | Alpharma Pharmaceuticals, Llc | Formulations and methods for attenuating respiratory depression induced by opioid overdose |
| US20120295911A1 (en) | 2010-11-29 | 2012-11-22 | Galleon Pharmaceuticals, Inc. | Novel Compounds and Compositions for Treatment of Breathing Control Disorders or Diseases |
| AU2011336764B2 (en) * | 2010-11-29 | 2017-02-23 | Galleon Pharmaceuticals, Inc. | Novel compounds as respiratory stimulants for treatment of breathing control disorders or diseases |
| SG11201503505QA (en) | 2012-11-15 | 2015-06-29 | Galleon Pharmaceuticals Inc | Novel orally bioavailable breathing control modulating compounds, and methods of using same |
| WO2016007729A1 (en) | 2014-07-09 | 2016-01-14 | Lightlake Therapeutics Inc. | Co-packaged drug products |
| HK1245079A1 (zh) | 2015-06-30 | 2018-08-24 | 纽拉德有限公司 | 新颖呼吸控制调节化合物以及其制备和使用方法 |
| ES2925951T3 (es) | 2015-07-22 | 2022-10-20 | John Hsu | Composición que comprende un agente terapéutico y un estimulante respiratorio y métodos para su uso |
| EP3833346A4 (en) | 2018-08-08 | 2022-08-03 | Torralva Medical Therapeutics LLC | Compositions for opiate and opioid prevention and reversal, and methods of their use |
-
2022
- 2022-11-02 CA CA3236586A patent/CA3236586A1/en active Pending
- 2022-11-02 AU AU2022380482A patent/AU2022380482A1/en active Pending
- 2022-11-02 MX MX2024005389A patent/MX2024005389A/es unknown
- 2022-11-02 EP EP22890702.8A patent/EP4426308A4/en active Pending
- 2022-11-02 CN CN202280080555.4A patent/CN118488840A/zh active Pending
- 2022-11-02 JP JP2024525777A patent/JP2024540198A/ja active Pending
- 2022-11-02 WO PCT/US2022/048669 patent/WO2023081185A1/en not_active Ceased
- 2022-11-02 US US17/979,192 patent/US12138267B2/en active Active
- 2022-11-02 KR KR1020247018353A patent/KR20240101622A/ko active Pending
- 2022-11-02 TW TW111141904A patent/TW202333730A/zh unknown
-
2024
- 2024-08-06 US US18/795,777 patent/US20250032496A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024540198A5 (https=) | ||
| JP2019218397A5 (https=) | ||
| AU2019350264B2 (en) | α2-Adrenoceptor subtype C (alpha-2C) antagonists for the treatment of sleep apnea | |
| JP2025501169A5 (https=) | ||
| US20220218677A1 (en) | Arylquinoziline derivatives as alpha2-adrenoceptor subtype c (alpha-2c) antagonists for the treatment of sleep apnea | |
| JP2024516730A5 (https=) | ||
| JP2005029573A (ja) | 腫瘍転移抑制剤 | |
| US20250057828A1 (en) | Combination of an a2-adrenoceptor subtype c (alpha-2c) antagonist with a norepinephrine reuptake inhibitor for the treatment of sleep apnea | |
| US20250262181A1 (en) | Compositions and methods for stimulating ventilatory and/or respiratory | |
| US20250049779A1 (en) | Combination of an a2-adrenoceptor subtype c (alpha-2c) antagonist with a norepinephrine reuptake inhibitor for the treatment of sleep apnea | |
| US20220016113A1 (en) | ?2-adrenoceptor subtype c (alpha-2c) antagonists for the treatment of sleep apnea | |
| HK40044843A (en) | α2-ADRENOCEPTOR SUBTYPE C (ALPHA-2C) ANTAGONISTS FOR THE TREATMENT OF SLEEP APNEA | |
| JP2023526790A5 (https=) | ||
| HK40049552A (en) | α2-ADRENOCEPTOR SUBTYPE C (ALPHA-2C) ANTAGONISTS FOR THE TREATMENT OF SLEEP APNEA |